Related Experiment Video
Updated: Mar 11, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
Linc-ROR and its spliced variants 2 and 4 are significantly up-regulated in esophageal squamous cell carcinoma
Reza Sahebi1, Mahshid Malakootian2, Baharak Balalaee1
1Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
Objectives:
Similar characteristics of molecular pathways between cellular reprogramming events and tumorigenesis have been accentuated in recent years. Reprogramming-related transcription factors, also known as Yamanaka factors (OCT4, SOX2, KLF4, and c-MYC), are also well-known oncogenes promoting cancer initiation, progression, and cellular transformation into cancer stem cells. Long non-coding RNAs (lncRNAs) are a major class of RNA molecules with emerging roles in stem cell pluripotency, cellular reprogramming, cellular transformation, and tumorigenesis. The long intergenic non-coding RNA ROR (lincRNA-ROR, linc-ROR) acts as a regulator of cellular reprograming through sponging miR-145 that normally negatively regulates the expression of the stemness factors NANOG, OCT4, and SOX2.
Materials And Methods:
Here, we employed a real-time PCR approach to determine the expression patterns of linc-ROR and its two novel spliced variants (variants 2 and 4) in esophageal squamous cell carcinoma (ESCC).
Results:
The quantitative real-time RT-PCR results revealed a significant up-regulation of linc-ROR (P=0.0098) and its variants 2 (P=0.0250) and 4 (P=0.0002) in tumor samples of ESCC, compared to their matched non-tumor tissues obtained from the margin of same tumors. Our data also demonstrated a significant up-regulation of variant 4 in high-grade tumor samples, in comparison to the low-grade ones (P=0.04). Moreover, the ROC curve analysis demonstrated that the variant 4 of ROR has a potential to discriminate between tumor and non-tumor samples (AUC=0.66, P<0.05).
Conclusion:
Our data suggest a significant up-regulation of linc-ROR and its variants 2 and 4 in ESCC tissue samples.
Insights
Long non-coding RNA ROR (linc-ROR) and its variants are significantly upregulated in esophageal squamous cell carcinoma (ESCC). This suggests linc-ROR may play a role in ESCC development and progression.
Area of Science:
- Molecular biology
- Cancer research
- Epigenetics
Background:
- Cellular reprogramming shares molecular pathways with tumorigenesis.
- Yamanaka factors (OCT4, SOX2, KLF4, c-MYC) are oncogenes involved in cancer.
- Long non-coding RNAs (lncRNAs) regulate stemness, reprogramming, and cancer.
Purpose of the Study:
- Investigate the expression of lincRNA-ROR and its variants in esophageal squamous cell carcinoma (ESCC).
- Determine the correlation between linc-ROR expression and tumor grade.
- Assess the diagnostic potential of linc-ROR variants in ESCC.
Main Methods:
- Quantitative real-time RT-PCR was used to analyze linc-ROR and its spliced variants (2 and 4) expression.
- Expression levels were compared between ESCC tumor tissues and matched non-tumor tissues.
- Receiver Operating Characteristic (ROC) curve analysis was performed.
Main Results:
- linc-ROR and its variants 2 and 4 were significantly upregulated in ESCC tumors compared to non-tumor tissues.
- Variant 4 showed significant upregulation in high-grade ESCC tumors.
- ROC analysis indicated variant 4 can discriminate between tumor and non-tumor samples.
Conclusions:
- linc-ROR and its variants 2 and 4 are significantly upregulated in ESCC.
- linc-ROR variant 4 may serve as a potential biomarker for ESCC diagnosis and grading.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
RNA Splicing
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Non-LTR Retrotransposons
